These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9471600)

  • 1. [Effect of the angiotensin-converting enzyme inhibitor ramipril on the processes of lipid peroxidation on the status of the endogenous antioxidant system in patients with myocardial infarction].
    Davydov BV; Golikov PP; Marchenko VV; Riabinin VA; Golikov AP
    Patol Fiziol Eksp Ter; 1997; (4):3-5. PubMed ID: 9471600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dynamics of lipid peroxidation and antioxidant system in patients with severe combined trauma].
    Andreev AA; Kartavenko VI; Golikov PP; Davydov BV; Nikolaeva NIu
    Vopr Med Khim; 1998; 44(5):485-93. PubMed ID: 9916265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of olmesartan and ramipril on inflammatory response after myocardial infarction in rats.
    Sandmann S; Li J; Fritzenkötter C; Spormann J; Tiede K; Fischer JW; Unger T
    Blood Press; 2006; 15(2):116-28. PubMed ID: 16754275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ramipril.
    Smith WH; Ball SG
    Int J Clin Pract; 2000 May; 54(4):255-60. PubMed ID: 10912316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adding angiotensin II type 1 receptor blockade to angiotensin-converting enzyme inhibition limits myocyte remodeling after myocardial infarction.
    Kim YK; Mankad S; Kim SJ; Takagi G; Tamura T; Gerdes AM; Bishop SP; Kramer CM
    J Card Fail; 2003 Jun; 9(3):238-45. PubMed ID: 12815575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of angiotensin converting enzyme inhibitor and calcium channel blocker in the treatment of steroid-resistant idiopathic nephrotic syndrome.
    Kumar NS; Singh AK; Mishra RN; Prakash J
    J Assoc Physicians India; 2004 Jun; 52():454-8. PubMed ID: 15645954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is ramipril really better than other angiotensin-converting enzyme inhibitors after acute myocardial infarction?
    Tu K; Gunraj N; Mamdani M
    Am J Cardiol; 2006 Jul; 98(1):6-9. PubMed ID: 16784910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardioprotective effect of tetrahydrocurcumin and rutin on lipid peroxides and antioxidants in experimentally induced myocardial infarction in rats.
    Ali MS; Mudagal MP; Goli D
    Pharmazie; 2009 Feb; 64(2):132-6. PubMed ID: 19320287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The HOPE Study (Heart Outcomes Prevention Evaluation).
    Sleight P
    J Renin Angiotensin Aldosterone Syst; 2000 Mar; 1(1):18-20. PubMed ID: 11967789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of enalapril maleate and lozartan on the size of experimental myocardial infarction, hemoglobin affinity to oxygen and various parameters of lipid peroxidation].
    Gatsura SV; Zinchuk VV
    Eksp Klin Farmakol; 2004; 67(1):19-21. PubMed ID: 15079902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of cardiovascular events and microvascular complications in diabetes with ACE inhibitor treatment: HOPE and MICRO-HOPE.
    Gerstein HC
    Diabetes Metab Res Rev; 2002; 18 Suppl 3():S82-5. PubMed ID: 12324991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ramipril in nondiabetic nephropathy: improved parameters of oxidatives stress and potential modulation of advanced glycation end products.
    Sebeková K; Gazdíková K; Syrová D; Blazícek P; Schinzel R; Heidland A; Spustová V; Dzúrik R
    J Hum Hypertens; 2003 Apr; 17(4):265-70. PubMed ID: 12692571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ramipril on cardiac gene transcription levels of angiotensin II receptors after myocardial infarction.
    Zhu YC; Zhu YZ; Li J; Schäfer H; Schmidt WE; Unger T; Yao T
    Zhongguo Yao Li Xue Bao; 1999 Jun; 20(6):481-5. PubMed ID: 10678136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes and the HOPE study: implications for macrovascular and microvascular disease.
    Gerstein HC
    Int J Clin Pract Suppl; 2001 Jan; (117):8-12. PubMed ID: 11715357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of alpha-tocopherol on lipid peroxidation in isoproterenol induced myocardial infarction in rats.
    Ithayarasi AP; Devi CS
    Indian J Physiol Pharmacol; 1997 Oct; 41(4):369-76. PubMed ID: 10235659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of ramipril on the circadian periodicity of acute myocardial infarction.
    Dagenais GR; Pogue J; Teo KK; Lonn EM; Yusuf S;
    Am J Cardiol; 2006 Sep; 98(6):758-60. PubMed ID: 16950179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League.
    Lüders S; Schrader J; Berger J; Unger T; Zidek W; Böhm M; Middeke M; Motz W; Lübcke C; Gansz A; Brokamp L; Schmieder RE; Trenkwalder P; Haller H; Dominiak P;
    J Hypertens; 2008 Jul; 26(7):1487-96. PubMed ID: 18551027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of canrenoate plus angiotensin-converting enzyme inhibitors versus angiotensin-converting enzyme inhibitors alone on systolic and diastolic function in patients with acute anterior myocardial infarction.
    Di Pasquale P; Cannizzaro S; Scalzo S; Parrinello G; Fasullo S; Giambanco F; Fatta A; Paterna S
    Am Heart J; 2005 Nov; 150(5):919. PubMed ID: 16290961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction.
    Kompa AR; See F; Lewis DA; Adrahtas A; Cantwell DM; Wang BH; Krum H
    J Pharmacol Exp Ther; 2008 Jun; 325(3):741-50. PubMed ID: 18334667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.